Kanglin Biotechnology Announces $20 Million Series A Financing to Advance the Development of Gene Therapies - Phase 1 study and Investigator Initiated Trial evaluating KL003 for patients with beta thalassemia demonstrated an encouraging efficacy signal and favorable safety profile – - Manufacturing costs...

Gene Vectors Market Predicted to Rise at a 12.6% CAGR until 2031, Reaching US$ 3.4 billion: TMR Report Wilmington, Delaware, United States, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - TMR predicted that the gene vector market is likely to reach US$ 3.4 billion by 2031. Gene...

Viral Vector Vaccines Market Size to Surpass US$ 1.23 billion by 2033 | Persistence Market Research New York, May 19, 2023 (GLOBE NEWSWIRE) -- The global viral vector vaccines market was valued at US$ 738.4 million in 2022 and is projected to expand at a CAGR of 3.9% over the forecast period (2023...